P2Y(12) Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

Dual antiplatelet therapy with aspirin and a P2Y(12) receptor inhibitor represents the cornerstone therapy for patients with acute coronary syndromes or undergoing percutaneous interventions, leading to a reduction of subsequent ischemic events. Variable response to clopidogrel has received close at...

Descripción completa

Detalles Bibliográficos
Autores principales: Oprea, Adriana Dana, Popescu, Wanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590496/
https://www.ncbi.nlm.nih.gov/pubmed/23533940
http://dx.doi.org/10.1155/2013/195456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590496/
https://www.ncbi.nlm.nih.gov/pubmed/23533940
http://dx.doi.org/10.1155/2013/195456

Ejemplares similares